These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15718844)

  • 1. Changes over time in post-seroconversion CD4 cell counts in the Italian HIV-Seroconversion Study: 1985-2002.
    Dorrucci M; Phillips AN; Longo B; Rezza G;
    AIDS; 2005 Feb; 19(3):331-5. PubMed ID: 15718844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II.
    AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4 surveillance in Scotland: perspectives on severe HIV-related immunodeficiency. CD4 Collaborative Group.
    AIDS; 1997 Oct; 11(12):1509-17. PubMed ID: 9342074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and consequences of pregnancy in women with known duration of HIV infection. Italian Seroconversion Study Group.
    Alliegro MB; Dorrucci M; Phillips AN; Pezzotti P; Boros S; Zaccarelli M; Pristerà R; Rezza G
    Arch Intern Med; 1997 Dec 8-22; 157(22):2585-90. PubMed ID: 9531227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the rate of CD4+ T cell decrease and the year of human immunodeficiency virus (HIV) type 1 seroconversion among persons enrolled in the Swiss HIV cohort study.
    Vanhems P; Lambert J; Guerra M; Hirschel B; Allard R
    J Infect Dis; 1999 Dec; 180(6):1803-8. PubMed ID: 10558934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent infection with human immunodeficiency virus and possible rapid loss of CD4 T lymphocytes.
    Holmberg SD; Conley LJ; Luby SP; Cohn S; Wong LC; Vlahov D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):291-6. PubMed ID: 7788428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load.
    Torti C; Lapadula G; Barreiro P; Soriano V; Mandalia S; De Silvestri A; Suter F; Maggiolo F; Antinori A; Antonucci F; Maserati R; El Hamad I; Pierotti P; Sighinolfi L; Migliorino G; Ladisa N; Carosi G;
    J Antimicrob Chemother; 2007 Jun; 59(6):1141-7. PubMed ID: 17434879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4 lymphocyte counts within 24 months of human immunodeficiency virus seroconversion. Findings in the US Navy and Marine Corps. The Navy Retroviral Working Group.
    Gorham ED; Garland FC; Mayers DL; Goforth RR; Brodine SK; Wiess PJ; McNally MS
    Arch Intern Med; 1993 Apr; 153(7):869-76. PubMed ID: 8096691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
    Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
    Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.
    Lapadula G; Torti C; Maggiolo F; Casari S; Suter F; Minoli L; Pezzoli C; Di Pietro M; Migliorino G; Ouiros-Roldan E; Ladisa N; Sighinolfi L; Costarelli S; Carosi G;
    Antivir Ther; 2007; 12(6):941-7. PubMed ID: 17926648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival from HIV-1 seroconversion in Southern Africa: a retrospective cohort study in nearly 2000 gold-miners over 10 years of follow-up.
    Glynn JR; Sonnenberg P; Nelson G; Bester A; Shearer S; Murray J
    AIDS; 2007 Mar; 21(5):625-32. PubMed ID: 17314525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal trends of initial CD4 cell counts following human immunodeficiency virus seroconversion in Italy, 1985-1992. The Human Immunodeficiency Virus Italian Seroconversion Study.
    Galai N; Lepri AC; Vlahov D; Pezzotti P; Sinicco A; Rezza G
    Am J Epidemiol; 1996 Feb; 143(3):278-82. PubMed ID: 8561162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of skin disorders in human immunodeficiency virus-infected patients in Singapore and the relationship to CD4 lymphocyte counts.
    Goh BK; Chan RK; Sen P; Theng CT; Tan HH; Wu YJ; Paton NI
    Int J Dermatol; 2007 Jul; 46(7):695-9. PubMed ID: 17614796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ and CD8+ lymphocytes and clinical features of HIV seropositive Nigerians on presentation.
    Onyemelukwe GC; Musa BO
    Afr J Med Med Sci; 2002 Sep; 31(3):229-33. PubMed ID: 12751562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low CD4 T cell counts before HIV-1 seroconversion do not affect disease progression in Ethiopian factory workers.
    Mekonnen Y; Geskus RB; Hendriks JC; Messele T; Borghans J; Miedema F; Wolday D; Coutinho RA; Dukers NH
    J Infect Dis; 2005 Sep; 192(5):739-48. PubMed ID: 16088823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD; Keruly JC
    Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oro-facial lesions and CD4 counts associated with HIV/AIDS in an adult population in Oyo State, Nigeria.
    Adurogbangba MI; Aderinokun GA; Odaibo GN; Olaleye OD; Lawoyin TO
    Oral Dis; 2004 Nov; 10(6):319-26. PubMed ID: 15533205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
    French M; Keane N; McKinnon E; Phung S; Price P
    HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populations.
    Williams BG; Korenromp EL; Gouws E; Schmid GP; Auvert B; Dye C
    J Infect Dis; 2006 Nov; 194(10):1450-8. PubMed ID: 17054076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.